Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astera Labs, Inc.ALAB · Entity 1853 | Director · President and COO | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astera Labs, Inc.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,119,038 |
Ending reported balance
After 2026-08-17 transaction · row 18
18 source rows · reconciled sequenceRow 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,209,090 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,208,041 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,206,057 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,205,000 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,201,500 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,198,975 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,181,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,177,889 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,172,440 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,170,830 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,168,214 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,161,730 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,153,738 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,143,300 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,140,354 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,138,572 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,131,646 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,119,038 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust 1 | 5,290,402 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 19
Holding and transaction disclosures are not merged.
1 source rowRow 19 · Balance 5,290,402 F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust 2 | 615,000 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 20
Holding and transaction disclosures are not merged.
1 source rowRow 20 · Balance 615,000 F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust 3 | 615,000 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 21
Holding and transaction disclosures are not merged.
1 source rowRow 21 · Balance 615,000 F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F20: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F21: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F22: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2025 Filed Feb 21, 2025 22:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 151,238 | $89.72 | $13,568,665.02 |
DisclosureSEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,398,385 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.3050 to $90.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 22:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 141,370 | $88.92 | $12,571,214.15 |
DisclosureSEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,549,623 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.3100 to $89.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 22:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,342 | $87.83 | $1,171,769.16 |
DisclosureSEC source: 0001736297-25-000013 · wk-form4_1740177263.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,690,993 F1 · kind: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.3100 to $88.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 968 | $99.59 | $96,402.35 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 18 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 775,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.4500 to $99.7500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,504 | $98.75 | $543,493.58 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 17 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 775,968 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.4500 to $99.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,015 | $98.00 | $687,502.97 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 16 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 781,472 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.4500 to $98.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 24,595 | $96.88 | $2,382,783.28 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 15 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 788,487 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.4500 to $97.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,398 | $95.90 | $709,451.92 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 14 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 813,082 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.4500 to $96.4450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 14,520 | $94.76 | $1,375,903.58 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 13 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 820,480 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.4500 to $95.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 968 | $99.59 | $96,402.44 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 12 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 775,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.4500 to $99.7500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,504 | $98.75 | $543,494.13 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 11 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 775,968 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.4500 to $99.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,015 | $98.00 | $687,502.97 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 781,472 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.4500 to $98.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 24,596 | $96.88 | $2,382,880.16 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 788,487 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.4500 to $97.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,397 | $95.90 | $709,356.03 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 813,083 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.4500 to $96.4450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 14,520 | $94.76 | $1,375,903.58 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 820,480 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.4500 to $95.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 10,002 | $99.59 | $996,093.18 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,305,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.4500 to $99.7500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 56,874 | $98.75 | $5,616,045.88 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,315,547 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.4500 to $99.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 72,489 | $98.00 | $7,104,269.95 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,372,421 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.4500 to $98.4450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 254,160 | $96.88 | $24,623,224.13 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,444,910 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.4500 to $97.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 76,443 | $95.90 | $7,330,707.88 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,699,070 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.4500 to $96.4450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:30 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 150,032 | $94.76 | $14,216,912.29 |
DisclosureSEC source: 0001736297-24-000045 · wk-form4_1731447022.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,775,513 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.4500 to $95.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:10 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 20,000 | $69.44 | $1,388,778.00 |
DisclosureSEC source: 0001736297-24-000041 · wk-form4_1729023013.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 835,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F4 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:10 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 20,000 | $69.44 | $1,388,714.00 |
DisclosureSEC source: 0001736297-24-000041 · wk-form4_1729023013.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 835,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:10 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,000 | $69.48 | $4,863,691.00 |
DisclosureSEC source: 0001736297-24-000041 · wk-form4_1729023013.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,925,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:18 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 14,200 | $45.09 | $640,253.86 |
DisclosureSEC source: 0001736297-24-000030 · wk-form4_1726777127.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 3 Disclosed balance after: 855,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.0000 to $45.3200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:18 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 14,200 | $45.09 | $640,319.18 |
DisclosureSEC source: 0001736297-24-000030 · wk-form4_1726777127.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 2 Disclosed balance after: 855,000 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.0000 to $45.3600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:18 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,652 | $46.11 | $260,610.89 |
DisclosureSEC source: 0001736297-24-000030 · wk-form4_1726777127.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 6,995,545 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.0000 to $46.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:18 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 42,649 | $45.36 | $1,934,537.32 |
DisclosureSEC source: 0001736297-24-000030 · wk-form4_1726777127.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Indirect · By Trust 1 Disclosed balance after: 7,001,197 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.0000 to $45.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 100 | $47.85 | $4,785.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 13 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 3 Disclosed balance after: 869,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 300 | $46.16 | $13,848.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 12 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 3 Disclosed balance after: 869,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.13 to $46.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,400 | $45.05 | $243,270.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 11 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 3 Disclosed balance after: 869,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 100 | $47.85 | $4,785.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 10 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 2 Disclosed balance after: 869,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F10 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 300 | $46.16 | $13,848.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 9 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 2 Disclosed balance after: 869,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.13 to $46.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,400 | $45.08 | $243,432.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 8 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 2 Disclosed balance after: 869,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 600 | $47.85 | $28,710.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 7 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,043,846 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,200 | $46.11 | $101,442.00 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 6 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,044,446 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.84 to $46.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 6,499 | $45.03 | $292,649.97 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 5 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,046,646 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.80 to $45.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 3,803 | $44.21 | $168,130.63 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 4 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,053,145 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.79 to $44.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,237 | $43.12 | $312,059.44 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 3 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,056,948 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.79 to $43.77. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 20,472 | $42.24 | $864,737.28 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 2 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,064,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.79 to $42.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:07 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 20,888 | $41.45 | $865,807.60 |
DisclosureSEC source: 0001736297-24-000029 · wk-form4_1725480429.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust 1 Disclosed balance after: 7,084,657 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.79 to $41.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 24, 2024 Filed Mar 21, 2024 20:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | GrantCommon Stock | 2,704,335 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-034776 · ownership.xml · nonDerivative · entry 1 Gajendra Sanjay · CIK 0001998179 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,704,335 F1 · date: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F2 · shares: These shares represent an award of restricted stock units ("RSUs") granted on January 24, 2024 under the Astera Labs, Inc. Amended and Restated 2018 Equity Incentive Plan. Such award vests upon satisfaction of both (i) a time-based condition, which provides that the RSUs shall vest as to 25% on February 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, and (ii) a performance-based condition, which is satisfied upon the occurrence of a change in control of the Issuer or the consummation of an initial public offering of the Issuer's equity securities, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.